India
Corporate Office - Noida
Operations, distribution & regulatory
Established 2024 - India - Toronto
Quality medicines that patients can actually afford.
Oncology and supportive-care medicines for Indian hospitals and patients, priced so that long-term treatment stays possible. Built with international association and a patient-first outlook.
- Prescription-grade oncology range
- Institutional & distributor supply
- Two-day enquiry response
Our vision
“Quality healthcare should not be a privilege. It should be accessible to everyone.”
Paclitaxel Protein-bound Particles
Paclitaxel
Abiraterone Acetate
Gemcitabine
Leuprolide Acetate
Acalabrutinib
Fosaprepitant Dimeglumine
Fulvestrant
Olaparib
Docetaxel
Enzalutamide
5-Fluorouracil
Benzydamine Mouth Wash
Paclitaxel Protein-bound Particles
Paclitaxel
Abiraterone Acetate
Gemcitabine
Leuprolide Acetate
Acalabrutinib
Fosaprepitant Dimeglumine
Fulvestrant
Olaparib
Docetaxel
Enzalutamide
5-Fluorouracil
Benzydamine Mouth Wash
Product range
Four ways we support cancer care.
2024
Established in India, with a corporate office in Noida and an overseas office near Toronto.
Who we are
A healthcare initiative built around one question: can the patient keep taking the medicine?
Malta International Pharma is a healthcare-focused pharmaceutical initiative established in 2024 with a clear and meaningful objective: to contribute towards making quality medicines more affordable and accessible to patients across India.
With international association and exposure, including the involvement of NRI Mr. Yashwant Singh and an office in Toronto, Canada, the company is being built to hold a strong and responsible presence in the Indian pharmaceutical market.
13
Products in the range
Injections, tablets, capsules and oral care
13
Molecules
Taxanes to targeted therapies
11
Therapeutic areas
Solid tumours, haematology, supportive care
2
Countries
India operations, Toronto office
Featured products
Oncology injectables, oral therapies and supportive care.
Injections
Nab PACLITECH
Paclitaxel (Protein-bound Particles) for Injectable Suspension
Lyophilised powder for injectable suspension
100 mg
Injections
Pacli TECH
Paclitaxel Injection
Concentrate for solution for infusion
30 mg100 mg260 mg
Tablets
PROSTIGA
Abiraterone Acetate Tablets
Film-coated tablets
250 mg500 mg
Injections
Gem TECH
Gemcitabine Injection
Ready-to-use sterile solution for infusion
200 mg1 gm1.4 gm
Tablets
Acala TECH
Acalabrutinib Tablets
Film-coated tablets
100 mg
Tablets
Ola TECH
Olaparib Tablets
Film-coated tablets
100 mg150 mg
Injections
Doce TECH (RTU)
Docetaxel Injection (Ready-to-Use)
One-vial concentrate, ready to dilute
20 mg80 mg120 mg
Capsules
Enza TECH
Enzalutamide Capsules
Soft gelatin capsules (40 mg) · Film-coated tablets (160 mg)
40 mg80 mg160 mg
Our commitment
Four principles we are building the company on.
Quality, accessibility, affordability and responsibility. Not slogans, but the criteria each product and partnership is measured against.
Quality
A strong focus on product quality, reliability and responsible pharmaceutical practice, from sourcing to the last mile.
Accessibility
Working so that essential medicines reach patients and treating hospitals across India, not only the metros.
Affordability
Reducing the financial burden of long-term and critical treatment, so therapy is not abandoned midway.
Responsibility
Integrity, transparency and a genuine commitment to the healthcare ecosystem we operate in.
How we work
From qualified source to hospital pharmacy.
-
Sourcing & qualification
Each molecule is sourced through qualified manufacturing partners with international exposure, and evaluated for quality and regulatory standing before it enters our list.
-
Quality documentation
Certificates of analysis, stability data and regulatory documents travel with every batch so hospital pharmacies can verify what they receive.
-
Distribution & cold chain
Injectables that need 2-8 degrees C storage move through temperature-controlled logistics to oncology centres and licensed distributors.
-
After-supply support
A single point of contact for availability, lead times and product queries, so procurement teams are never left guessing.
Where we focus
Long-term therapies, oncology and other serious conditions.
Continuous treatment places pressure on household finances for months and years. That is where a lower price is not a discount. It is the difference between finishing therapy and stopping it.
- Breast cancer
- Prostate cancer
- Lung cancer (NSCLC)
- Ovarian cancer
- Pancreatic cancer
- Colorectal & GI cancers
- Gastric cancer
- Bladder cancer
- Head & neck cancer
- Haematological malignancies
- Supportive care
Common questions
Before you send an enquiry.
Who can purchase products from Malta International Pharma?
Our products are prescription medicines supplied to hospitals, oncology centres, institutional pharmacies and licensed distributors. Individual patients should obtain them through their treating hospital or a licensed pharmacy with a valid prescription.
Which therapeutic areas do you cover?
The current portfolio focuses on oncology: taxanes, antimetabolites, hormonal and targeted therapies for breast, prostate, lung, ovarian, pancreatic, gastrointestinal and haematological cancers, along with supportive-care products such as antiemetic injections and benzydamine mouthwash.
How do I get pricing for bulk or institutional supply?
Send us the molecule, strength, approximate monthly requirement and delivery location through the enquiry form. We respond within two working days with availability, lead time and pricing.
Where are you located?
Our corporate office is at C-22, 5th Floor, Tower C, Spectrum Mall, GH-ECO City, Sector 75, Noida, Uttar Pradesh. Our overseas office is at 800 Constellation Drive, Mississauga, Ontario L5R 3L6, in the Greater Toronto Area, Canada.
Can you share regulatory documents for a product?
Yes. Product-specific documentation is shared with institutional buyers and distributors on request as part of the enquiry process.
International outlook
Rooted in India. Connected to Toronto.
Canada
Overseas Office - Greater Toronto
International association & sourcing